{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:00:21Z","timestamp":1791540021389,"version":"4.3.4"},"reference-count":49,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi241108-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>The American Heart Association\u2019s Predicting Risk of Cardiovascular Disease Events (PREVENT) equations were developed to extend and improve on previous cardiovascular disease (CVD) risk assessments for the purpose of treatment initiation and patient-clinician communication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241108-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess prognostic capabilities, calibration, and discrimination of the PREVENT equations in a study sample representative of the noninstitutionalized, US general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241108-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This prognostic study used data from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2010 data cycles. Participants included adults for whom 10-year follow-up data were available. Data curation and analyses took place from December 2023 through May 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241108-7\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Primary measures were risk estimated by the PREVENT equations, as well as risk estimates from the previous Pooled Cohort Equations (PCEs). The primary outcome was composite CVD-related mortality at 10 years of follow-up. Additional analyses compared the PREVENT equations against the PCEs. Model discrimination was assessed with receiver-operator characteristic curves and Harrell C statistic from proportional hazard regression; model calibration was determined as the slope of predicted versus observed risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241108-8\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study cohort, accounting for NHANES complex survey design, consisted of 172.9 million participants (mean age, 45.0 years [95% CI, 44.6-45.4 years]; 52.1% women [95% CI, 51.5%-52.6%]). In analyses adjusted for the NHANES survey design, a 1% increase in PREVENT risk estimates was statistically significantly associated with increased CVD mortality risk (hazard ratio, 1.090; 95% CI, 1.087-1.094). PREVENT risk scores demonstrated excellent discrimination (C statistic, 0.890; 95% CI, 0.881-0.898) but moderate underfitting of the model (calibration slope, 1.13; 95% CI, 1.06-1.21). PREVENT risk models performed statistically significantly better than the PCEs, as assessed by the net reclassification index (0.093; 95% CI, 0.073-0.115).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi241108-9\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this prognostic study of the PREVENT equations, PREVENT risk estimates demonstrated excellent discrimination and only modest discrepancies in calibration. These findings provided evidence supporting utilization of the PREVENT equations for application in the intended population as suggested by the American Heart Association.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.38311","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T11:31:19Z","timestamp":1728646279000},"page":"e2438311","source":"Crossref","is-referenced-by-count":59,"title":["External Validation of the American Heart Association PREVENT Cardiovascular Disease Risk Equations"],"prefix":"10.1001","volume":"7","author":[{"given":"Britton","family":"Scheuermann","sequence":"first","affiliation":[{"name":"College of Health and Human Sciences, Kansas State University, Manhattan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trenton","family":"Colburn","sequence":"additional","affiliation":[{"name":"Department of Physician Assistant Studies, Kansas State University, Manhattan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Hakeem","sequence":"additional","affiliation":[{"name":"Cotton O\u2019Neil Heart Center, Stormont Vail Health, Topeka, Kansas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen Hoe","family":"Chow","sequence":"additional","affiliation":[{"name":"Cotton O\u2019Neil Heart Center, Stormont Vail Health, Topeka, Kansas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Ade","sequence":"additional","affiliation":[{"name":"College of Health and Human Sciences, Kansas State University, Manhattan"},{"name":"Department of Physician Assistant Studies, Kansas State University, Manhattan"},{"name":"Johnson Cancer Research Center, Kansas State University, Manhattan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,10,11]]},"reference":[{"issue":"25","key":"zoi241108r1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 Study.","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"zoi241108r2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jacc.2022.05.033","article-title":"Cardiovascular disease projections in the United States based on the 2020 Census estimates.","volume":"80","author":"Mohebi","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"zoi241108r3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association\u2019s PREVENT Equations.","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"issue":"24","key":"zoi241108r4","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association.","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"issue":"25 Pt B","key":"zoi241108r5","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"zoi241108r7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.7326\/L15-5093-2","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD).","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"issue":"159","key":"zoi241108r9","first-page":"1","article-title":"National Health and Nutrition Examination Survey: estimation procedures, 2007-2010.","author":"Mirel","year":"2013","journal-title":"Vital Health Stat 2"},{"issue":"19","key":"zoi241108r10","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin c-based equations to estimate GFR without race.","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi241108r11","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","article-title":"Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values.","volume":"53","author":"Levey","year":"2007","journal-title":"Clin Chem"},{"issue":"5","key":"zoi241108r12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/eurheartj\/ehy686","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension.","volume":"40","author":"Williams","year":"2019","journal-title":"Eur Heart J"},{"key":"zoi241108r13","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus.","volume":"37","author":"American Diabetes Association","year":"2014","journal-title":"Diabetes Care"},{"issue":"11","key":"zoi241108r14","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1038\/s41591-019-0627-8","article-title":"Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease.","volume":"25","author":"Lees","year":"2019","journal-title":"Nat Med"},{"issue":"8","key":"zoi241108r15","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1097\/MLR.0000000000000753","article-title":"Using self-reports or claims to assess disease prevalence: it\u2019s complicated.","volume":"55","author":"St Clair","year":"2017","journal-title":"Med Care"},{"issue":"6","key":"zoi241108r17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks.","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"zoi241108r18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jaccao.2022.08.002","article-title":"Considerations of competing risks analysis in cardio-oncology studies: JACC: CardioOncology state-of-the-art review.","volume":"4","author":"Li","year":"2022","journal-title":"JACC CardioOncol"},{"issue":"13","key":"zoi241108r19","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1002\/sim.1802","article-title":"Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation.","volume":"23","author":"Pencina","year":"2004","journal-title":"Stat Med"},{"issue":"4","key":"zoi241108r21","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1214\/aos\/1176350161","article-title":"Rejoinder: jackknife, bootstrap and other resampling methods in regression analysis.","volume":"14","author":"Wu","year":"1986","journal-title":"Ann Stat"},{"issue":"2","key":"zoi241108r22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1541-0420.2011.01671.x","article-title":"Evaluating prognostic accuracy of biomarkers under competing risk.","volume":"68","author":"Zheng","year":"2012","journal-title":"Biometrics"},{"issue":"1","key":"zoi241108r23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1541-0420.2009.01246.x","article-title":"Semiparametric models of time-dependent predictive values of prognostic biomarkers.","volume":"66","author":"Zheng","year":"2010","journal-title":"Biometrics"},{"issue":"10","key":"zoi241108r24","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.jacc.2019.07.011","article-title":"Erratum for 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"zoi241108r25","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/jama.2014.2630","article-title":"Validation of the atherosclerotic cardiovascular disease pooled cohort risk equations.","volume":"311","author":"Muntner","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"zoi241108r26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/oxfordjournals.aje.a113284","article-title":"A review of goodness of fit statistics for use in the development of logistic regression models.","volume":"115","author":"Lemeshow","year":"1982","journal-title":"Am J Epidemiol"},{"issue":"1","key":"zoi241108r27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","article-title":"Calibration: the Achilles heel of predictive analytics.","volume":"17","author":"van Calster","year":"2019","journal-title":"BMC Med"},{"issue":"21","key":"zoi241108r28","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1002\/sim.8570","article-title":"Graphical calibration curves and the integrated calibration index (ICI) for survival models.","volume":"39","author":"Austin","year":"2020","journal-title":"Stat Med"},{"issue":"4","key":"zoi241108r29","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1177\/0962280213497434","article-title":"Assessing calibration of prognostic risk scores.","volume":"25","author":"Crowson","year":"2016","journal-title":"Stat Methods Med Res"},{"issue":"2","key":"zoi241108r30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"issue":"7","key":"zoi241108r31","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013234","article-title":"Predicted versus observed major adverse cardiac event risk in women with evidence of ischemia and no obstructive coronary artery disease: a report from WISE (Women's Ischemia Syndrome Evaluation).","volume":"9","author":"Sedlak","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"zoi241108r35","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1136\/bmj.39609.449676.25","article-title":"Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.","volume":"336","author":"Hippisley-Cox","year":"2008","journal-title":"BMJ"},{"issue":"11","key":"zoi241108r36","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J"},{"issue":"14","key":"zoi241108r37","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jacc.2009.07.020","article-title":"Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.","volume":"54","author":"Cooney","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"zoi241108r38","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrcardio.2015.28","article-title":"Cardiovascular risk assessment: a global perspective.","volume":"12","author":"Zhao","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"zoi241108r39","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1056\/NEJMms2004740","article-title":"Hidden in plain sight: reconsidering the use of race correction in clinical algorithms.","volume":"383","author":"Vyas","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi241108r40","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.121.058311","article-title":"Associations of clinical and social risk factors with racial differences in premature cardiovascular disease.","volume":"146","author":"Shah","year":"2022","journal-title":"Circulation"},{"issue":"3","key":"zoi241108r41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1161\/CIRCULATIONAHA.122.061991","article-title":"Social and psychosocial determinants of racial and ethnic differences in cardiovascular health in the United States population.","volume":"147","author":"Shah","year":"2023","journal-title":"Circulation"},{"issue":"14","key":"zoi241108r42","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015598","article-title":"Anticancer therapy-related increases in arterial stiffness: a systematic review and meta-analysis.","volume":"9","author":"Parr","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"1-2","key":"zoi241108r43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/aac2.12033","article-title":"Anthracycline chemotherapy-mediated vascular dysfunction as a model of accelerated vascular aging.","volume":"2","author":"Clayton","year":"2021","journal-title":"Aging Cancer"},{"issue":"4","key":"zoi241108r44","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.001891","article-title":"Treatment, behavioral, and psychosocial components of cardiovascular disease risk among survivors of childhood and young adult cancer.","volume":"4","author":"Berkman","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"zoi241108r45","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","article-title":"Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study.","volume":"34","author":"Armenian","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi241108r46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jacc.2022.04.042","article-title":"Cardiovascular disease risk among cancer survivors: the Atherosclerosis Risk In Communities (ARIC) Study.","volume":"80","author":"Florido","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"zoi241108r47","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.032616","article-title":"Associations of cerebrovascular regulation and arterial stiffness with cerebral small vessel disease: a systematic review and meta-analysis.","volume":"12","author":"Scheuermann","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"zoi241108r48","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.jcmg.2015.06.019","article-title":"Predictors of long-term healthy arterial aging: coronary artery calcium nondevelopment in the MESA Study.","volume":"8","author":"Whelton","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"zoi241108r49","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1001\/jamaophthalmol.2018.3001","article-title":"Assessing the precision of ICD-10 codes for uveitis in 2 electronic health record systems.","volume":"136","author":"Palestine","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"zoi241108r20","doi-asserted-by":"crossref","DOI":"10.1002\/0471722146","volume-title":"Applied Logistic Regression","author":"Hosmer","year":"2000","edition":"2nd ed"},{"key":"zoi241108r6","unstructured":"National Center for Health Statistics. NHANES survey methods analytic and guidelines. Accessed March 2024. https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/analyticguidelines.aspx"},{"key":"zoi241108r8","unstructured":"National Center for Health Statistics. Continuous NHANES. Accessed September 5, 2024. https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/continuousnhanes\/default.aspx"},{"key":"zoi241108r16","unstructured":"National Center for Health Statistics. NCHS data linked to NDI mortality files. Accessed September 5, 2024. https:\/\/www.cdc.gov\/nchs\/data-linkage\/mortality.htm"},{"key":"zoi241108r32","unstructured":"Newson? R. SOMERSD: Stata module to calculate Kendall's tau-a, Somers' D and median differences. 2020. Accessed September 11, 2024. https:\/\/ideas.repec.org\/c\/boc\/bocode\/s336401.html"},{"key":"zoi241108r33","unstructured":"De Cock? B, Nieboer? D, Van Calster? B, Steyerberg? E, Vergouwe? Y. The CalibrationCurves package: assessing the agreement between observed outcomes and predictions. Accessed September 5, 2024. https:\/\/cran.r-project.org\/package=CalibrationCurves"},{"key":"zoi241108r34","unstructured":"Inoue? E. CRAN package \u2018nricens\u2019. May 30, 2018. Accessed September 5, 2024. https:\/\/cran.r-project.org\/web\/packages\/nricens\/index.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2824692\/scheuermann_2024_oi_241108_1727817886.22423.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T11:31:24Z","timestamp":1728646284000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2824692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,11]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.38311","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,11]]}}}